A 38-year-old man is brought to the emergency room because of diarrhea for 2 days. He has abdominal cramps and has also noticed a dark red tint to his stool. He returned from a trip to Mexico 3 weeks ago, where he completed a marathon. He has a history of mild anemia. He does not smoke and drinks 3–4 beers on weekends. He takes fish oil, a multivitamin, and iron supplements to improve his athletic performance. His temperature is 101.8°F (38.8°C), pulse is 65/min, and blood pressure is 120/75 mm Hg. Lungs are clear to auscultation. Cardiac examination shows no abnormalities. There is mild tenderness to palpation of the left lower quadrant without rebound or guarding. Laboratory studies show:
Hematocrit 37.1%
Leukocyte count 4,500/mm3
Platelet count 240,000/mm3
Serum
Na+ 136 mEq/L
K+ 4.5 mEq/L
Cl- 102 mEq/L
HCO3- 26 mEq/L
Urea nitrogen 14 mg/dL
Creatinine 1.2 mg/dL
Stool culture demonstrates organisms with ingested erythrocytes. In addition to supportive therapy, which of the following is the most appropriate next step in management?
Q52
A healthy 34-year-old woman comes to the physician for advice on UV protection. She works as an archaeologist and is required to work outside for extended periods of time. She is concerned about premature skin aging. The physician recommends sun-protective clothing and sunscreen. In order to protect effectively against photoaging, the sunscreen should contain which of the following active ingredients?
Q53
A 3-year-old girl with cystic fibrosis is brought to the physician for a follow-up examination. Her mother has noticed that the child has had multiple falls over the past 4 months while walking, especially in the evening. Her current medications include pancreatic enzyme supplements, an albuterol inhaler, and acetylcysteine. She is at the 10th percentile for height and the 5th percentile for weight. Examination shows dry skin, and cone shaped elevated papules on the trunk and extremities. There is an irregularly shaped foamy gray patch on the left conjunctiva. The remainder of the examination shows no abnormalities. Which of the following is the most appropriate next step in management?
Q54
A 23-year-old woman presents to her primary care provider complaining of diarrhea. She reports a 2 month history of 3-4 bloody stools per day as well as 10 pounds of unexpected weight loss. She has also developed intermittent mild gnawing lower abdominal pain. Her past medical history is unremarkable. She takes no medications and denies any drug allergies. Her family history is notable for colon cancer in her maternal aunt, rheumatoid arthritis in her paternal aunt, and Sjogren syndrome in her paternal grandmother. Her temperature is 99.1°F (37.3°C), blood pressure is 120/85 mmHg, pulse is 85/min, and respirations are 18/min. On exam, she has mild hypogastric tenderness to palpation. A stool guaiac test is positive. Flexible sigmoidoscopy demonstrates hyperemic and friable rectal mucosa. She is started on a medication to address her condition but presents to her physician one week later with a severe sunburn and skin itchiness following limited exposure to sunlight. Which of the following is the mechanism of action of the medication she received?
Q55
A 6-year-old boy is brought to the physician because of headache, cough, runny nose, and a low-grade fever since waking up that morning. He has been healthy except for a urinary tract infection one week ago that has resolved with trimethoprim-sulfamethoxazole therapy. Both parents have a history of allergic rhinitis. His temperature is 37.8°C (100°F). Physical exam shows rhinorrhea and tenderness over the frontal and maxillary sinuses. There is cervical lymphadenopathy. Laboratory studies show:
Hemoglobin 14.2 g/dL
Leukocyte count 2,700/mm3
Segmented neutrophils 30%
Bands 1%
Eosinophils 4%
Basophils 0%
Lymphocytes 56%
Monocytes 9%
Platelet count 155,000/mm3
Which of the following is the most likely underlying cause of this patient's symptoms?
Q56
A 54-year-old woman is brought to the emergency department by a nurse 30 minutes after receiving scheduled radiation therapy for papillary thyroid cancer. After the radioisotope was ingested, the physician realized that a much larger fixed dose was given instead of the appropriate dose based on radiation dosimetry. Which of the following pharmacotherapies should be administered immediately to prevent complications from this exposure?
Q57
A 13-year-old Caucasian male presents with his father to the pediatrician’s office complaining of left lower thigh pain. He reports slowly progressive pain over the distal aspect of his left thigh over the past three months. He denies any recent trauma to the area. His temperature is 100.9°F (38.3°C). On exam, there is swelling and tenderness overlying the inferior aspect of the left femoral diaphysis. Laboratory evaluation is notable for an elevated white blood cell (WBC) count and erythrocyte sedimentation rate (ESR). Biopsy of the lesion demonstrates sheets of monotonous small round blue cells with minimal cytoplasm. He is diagnosed and started on a medication that inhibits transcription by intercalating into DNA at the transcription initiation complex. Which of the following adverse events will this patient be at highest risk for following initiation of this medication?
Q58
A 60-year-old female presents to her primary care physician complaining of bloating and fatigue over the past year. On examination, she has abdominal distension and ascites. Abdominal imaging reveals a mass-like lesion affecting the left ovary. A biopsy of the lesion demonstrates serous cystadenocarcinoma. She is subsequently started on a chemotherapeutic medication known to stabilize polymerized microtubules. Which of the following complications should this patient be monitored for following initiation of this medication?
Q59
A 26-year-old man comes to the emergency department because of a 1-week history of worsening fatigue, nausea, and vomiting. Six weeks ago, he was diagnosed with latent tuberculosis and appropriate low-dose pharmacotherapy was initiated. Physical examination shows right upper quadrant tenderness and scleral icterus. Laboratory studies show elevated aminotransferases. Impaired function of which of the following pharmacokinetic processes is the most likely explanation for this patient's symptoms?
Q60
A 67-year-old male with a past medical history of diabetes type II, obesity, and hyperlipidemia presents to the general medical clinic with bilateral hearing loss. He also reports new onset vertigo and ataxia. The symptoms started a day after undergoing an uncomplicated cholecystectomy. If a drug given prophylactically just prior to surgery has caused this patient’s symptoms, what is the mechanism of action of the drug?
Antimicrobials US Medical PG Practice Questions and MCQs
Question 51: A 38-year-old man is brought to the emergency room because of diarrhea for 2 days. He has abdominal cramps and has also noticed a dark red tint to his stool. He returned from a trip to Mexico 3 weeks ago, where he completed a marathon. He has a history of mild anemia. He does not smoke and drinks 3–4 beers on weekends. He takes fish oil, a multivitamin, and iron supplements to improve his athletic performance. His temperature is 101.8°F (38.8°C), pulse is 65/min, and blood pressure is 120/75 mm Hg. Lungs are clear to auscultation. Cardiac examination shows no abnormalities. There is mild tenderness to palpation of the left lower quadrant without rebound or guarding. Laboratory studies show:
Hematocrit 37.1%
Leukocyte count 4,500/mm3
Platelet count 240,000/mm3
Serum
Na+ 136 mEq/L
K+ 4.5 mEq/L
Cl- 102 mEq/L
HCO3- 26 mEq/L
Urea nitrogen 14 mg/dL
Creatinine 1.2 mg/dL
Stool culture demonstrates organisms with ingested erythrocytes. In addition to supportive therapy, which of the following is the most appropriate next step in management?
A. Metronidazole (Correct Answer)
B. Paromomycin
C. Serological tests
D. Reassurance only
E. Praziquantel
Explanation: ***Metronidazole***
- The patient's history of recent travel to **Mexico**, bloody diarrhea, abdominal cramps, and the presence of organisms with **ingested erythrocytes** in stool culture are highly indicative of **amoebic dysentery** caused by *Entamoeba histolytica*.
- **Metronidazole** is the drug of choice for treating **invasive amoebiasis**, including amoebic dysentery and liver abscesses, by targeting the trophozoites in the intestinal wall and tissue.
- Note: Complete treatment typically includes a **luminal agent** (paromomycin or iodoquinol) after metronidazole to eradicate intestinal cysts and prevent relapse.
*Paromomycin*
- **Paromomycin** is a **luminal amoebicide** used to eradicate cysts in the colon, either as **monotherapy for asymptomatic carriers** or as **follow-up therapy after metronidazole** in invasive disease.
- However, as the **initial treatment** for acute invasive amoebiasis, metronidazole is preferred because paromomycin is poorly absorbed and does not effectively reach tissue-invasive trophozoites.
*Serological tests*
- **Serological tests** for *Entamoeba histolytica* can be useful for diagnosing **extra-intestinal amoebiasis** (e.g., amoebic liver abscess) or for confirming past exposure.
- However, they are generally **not helpful for acute diagnosis** of amoebic dysentery, as antibodies may take time to develop and persist for long periods after infection.
*Reassurance only*
- This patient presents with an acute febrile illness, **bloody diarrhea**, and clear evidence of an **invasive pathogen** on stool culture.
- Reassurance only would be **inappropriate** and potentially harmful given the risk of severe complications from untreated amoebic dysentery.
*Praziquantel*
- **Praziquantel** is an **anti-helminthic** drug used to treat infections caused by **flukes** (e.g., Schistosoma, Clonorchis) and **tapeworms** (e.g., Taenia).
- It has no activity against **protozoal infections** like *Entamoeba histolytica*.
Question 52: A healthy 34-year-old woman comes to the physician for advice on UV protection. She works as an archaeologist and is required to work outside for extended periods of time. She is concerned about premature skin aging. The physician recommends sun-protective clothing and sunscreen. In order to protect effectively against photoaging, the sunscreen should contain which of the following active ingredients?
A. Zinc oxide (Correct Answer)
B. Vitamin E
C. Para-aminobenzoic acid
D. Trimethoprim/sulfamethoxazole
E. Trolamine salicylate
Explanation: **Zinc oxide**
- **Zinc oxide** is a physical sunscreen that provides broad-spectrum protection by **blocking both UVA and UVB rays**.
- **UVA rays** are primarily responsible for **photoaging**, and physical blockers like zinc oxide are highly effective against them.
*Vitamin E*
- **Vitamin E** is an antioxidant that helps prevent cellular damage from free radicals, but it does **not provide direct protection against UV radiation** as a primary sunscreen ingredient.
- While commonly used in skincare for its **antioxidant properties**, it is not an active UV-blocking agent.
*Para-aminobenzoic acid*
- **Para-aminobenzoic acid (PABA)** is an older chemical sunscreen ingredient that primarily **blocks UVB rays**.
- It is often **associated with allergic reactions** and photosensitivity, and does not offer sufficient UVA protection for broad-spectrum coverage.
*Trimethoprim/sulfamethoxazole*
- **Trimethoprim/sulfamethoxazole** is an antibiotic combination used to treat various infections and has **no role in UV protection**.
- It is a medication and not an ingredient found in sunscreens for UV blocking.
*Trolamine salicylate*
- **Trolamine salicylate** is a topical analgesic ingredient often found in pain-relief creams and is **not an active sunscreen agent**.
- It has **no UV filtering properties** and does not protect against sun damage or photoaging.
Question 53: A 3-year-old girl with cystic fibrosis is brought to the physician for a follow-up examination. Her mother has noticed that the child has had multiple falls over the past 4 months while walking, especially in the evening. Her current medications include pancreatic enzyme supplements, an albuterol inhaler, and acetylcysteine. She is at the 10th percentile for height and the 5th percentile for weight. Examination shows dry skin, and cone shaped elevated papules on the trunk and extremities. There is an irregularly shaped foamy gray patch on the left conjunctiva. The remainder of the examination shows no abnormalities. Which of the following is the most appropriate next step in management?
A. Administer niacin
B. Administer riboflavin
C. Administer vitamin A (Correct Answer)
D. Administer zinc
E. Administer lutein
Explanation: ***Administer vitamin A***
- The patient's symptoms, including **night blindness** (falls in the evening), **dry skin**, **follicular hyperkeratosis** (cone-shaped elevated papules), and **Bitot spots** (foamy gray patch on conjunctiva), are classic signs of **vitamin A deficiency**.
- **Cystic Fibrosis** patients are prone to **fat-soluble vitamin deficiencies** (A, D, E, K) due to pancreatic insufficiency and malabsorption.
*Administer niacin*
- **Niacin (B3) deficiency** causes **pellagra**, characterized by the "4 Ds": **dermatitis**, **diarrhea**, **dementia**, and **death**. These symptoms are not present in this patient.
- While cystic fibrosis can sometimes lead to general malabsorption, specific signs of pellagra are absent.
*Administer riboflavin*
- **Riboflavin (B2) deficiency** typically presents with **chelosis** (cracked lips), **angular stomatitis**, **glossitis**, and **seborrheic dermatitis**.
- The patient's symptoms do not align with riboflavin deficiency.
*Administer zinc*
- **Zinc deficiency** can cause **growth retardation**, **diarrhea**, **alopecia**, and characteristic **periorificial and acral dermatitis**.
- Although malabsorption in cystic fibrosis can affect zinc levels, the specific constellation of symptoms points more directly to vitamin A deficiency.
*Administer lutein*
- **Lutein** is a carotenoid important for eye health, but its deficiency does not cause the widespread systemic symptoms related to night blindness and dermatological changes seen in this patient.
- It's not a primary vitamin, and its deficiency is not managed as acutely as vitamin A deficiency presenting with these severe symptoms.
Question 54: A 23-year-old woman presents to her primary care provider complaining of diarrhea. She reports a 2 month history of 3-4 bloody stools per day as well as 10 pounds of unexpected weight loss. She has also developed intermittent mild gnawing lower abdominal pain. Her past medical history is unremarkable. She takes no medications and denies any drug allergies. Her family history is notable for colon cancer in her maternal aunt, rheumatoid arthritis in her paternal aunt, and Sjogren syndrome in her paternal grandmother. Her temperature is 99.1°F (37.3°C), blood pressure is 120/85 mmHg, pulse is 85/min, and respirations are 18/min. On exam, she has mild hypogastric tenderness to palpation. A stool guaiac test is positive. Flexible sigmoidoscopy demonstrates hyperemic and friable rectal mucosa. She is started on a medication to address her condition but presents to her physician one week later with a severe sunburn and skin itchiness following limited exposure to sunlight. Which of the following is the mechanism of action of the medication she received?
A. Dihydrofolate reductase inhibitor
B. NF-kB inhibitor (Correct Answer)
C. COX inhibitor
D. Calcineurin inhibitor
E. DNA gyrase inhibitor
Explanation: ***NF-κB inhibitor***
- The patient's symptoms (bloody diarrhea, weight loss, abdominal pain, friable rectal mucosa) are highly suggestive of **ulcerative colitis**
- **Sulfasalazine**, a 5-aminosalicylate (5-ASA) drug, is a common first-line treatment for mild-to-moderate ulcerative colitis
- The active metabolite **mesalamine** exerts its anti-inflammatory effects primarily through **inhibition of NF-κB**, a key transcription factor that regulates inflammatory cytokine production
- The **sulfapyridine** component is responsible for the photosensitivity reaction (severe sunburn and skin itchiness after sun exposure) that this patient experienced
- Other mechanisms include prostaglandin inhibition, free radical scavenging, and modulation of leukocyte function, but **NF-κB inhibition is the predominant mechanism**
*COX inhibitor*
- While mesalamine does have some cyclooxygenase (COX) inhibitory activity and reduces prostaglandin synthesis, this is a **secondary mechanism** of action
- The primary anti-inflammatory effect of 5-ASA drugs in inflammatory bowel disease is through **NF-κB inhibition**, not COX inhibition
- Traditional NSAIDs (pure COX inhibitors) can actually worsen IBD symptoms, highlighting that COX inhibition alone is not the therapeutic mechanism
*Dihydrofolate reductase inhibitor*
- This mechanism describes **methotrexate**, an immunosuppressant used in more severe or refractory cases of inflammatory bowel disease, but not typically as a first-line agent
- Methotrexate is not associated with photosensitivity reactions in the manner seen with sulfasalazine
*Calcineurin inhibitor*
- **Calcineurin inhibitors** such as **cyclosporine** or **tacrolimus** are potent immunosuppressants typically reserved for severe, refractory cases of inflammatory bowel disease
- Their side effect profile includes nephrotoxicity, hypertension, and hirsutism, but not the characteristic photosensitivity seen with sulfasalazine
*DNA gyrase inhibitor*
- **DNA gyrase inhibitors** (fluoroquinolones) are antibiotics used to treat bacterial infections
- These are not used as primary treatment for inflammatory bowel disease, which is an immune-mediated condition
- While fluoroquinolones can cause photosensitivity, they would not be prescribed for ulcerative colitis management
Question 55: A 6-year-old boy is brought to the physician because of headache, cough, runny nose, and a low-grade fever since waking up that morning. He has been healthy except for a urinary tract infection one week ago that has resolved with trimethoprim-sulfamethoxazole therapy. Both parents have a history of allergic rhinitis. His temperature is 37.8°C (100°F). Physical exam shows rhinorrhea and tenderness over the frontal and maxillary sinuses. There is cervical lymphadenopathy. Laboratory studies show:
Hemoglobin 14.2 g/dL
Leukocyte count 2,700/mm3
Segmented neutrophils 30%
Bands 1%
Eosinophils 4%
Basophils 0%
Lymphocytes 56%
Monocytes 9%
Platelet count 155,000/mm3
Which of the following is the most likely underlying cause of this patient's symptoms?
A. CMV infection
B. EBV infection
C. Acute lymphocytic leukemia
D. Medication side effect (Correct Answer)
E. Acute myelogenous leukemia
Explanation: ***Medication side effect***
- The patient's recent **trimethoprim-sulfamethoxazole (TMP-SMX)** treatment and current **leukopenia** (WBC 2,700/mm³, normal 5,000-10,000/mm³) with **neutropenia** (absolute neutrophil count ~840/mm³) strongly suggest **drug-induced bone marrow suppression**.
- TMP-SMX is a folate antagonist known to cause dose-dependent bone marrow suppression, particularly affecting neutrophils and occasionally platelets. The platelet count (155,000/mm³) is at the lower limit of normal, which may represent early marrow effect.
- While the patient's current symptoms (rhinorrhea, cough, sinus tenderness, low-grade fever) suggest an **acute viral upper respiratory infection**, the question asks for the "most likely underlying cause." The **leukopenia with neutropenia** is the most significant abnormal finding and represents the drug effect that predisposes to or complicates infections.
- The combination of recent antibiotic exposure and cytopenias makes medication side effect the primary diagnosis.
*CMV infection*
- CMV can cause **leukopenia**, but typically presents with more prominent constitutional symptoms including prolonged fever, malaise, hepatosplenomegaly, and atypical lymphocytosis.
- The acute onset of URI symptoms and temporal relationship to antibiotic use makes drug-induced marrow suppression more likely.
*EBV infection*
- EBV (infectious mononucleosis) characteristically causes **lymphocytosis with atypical lymphocytes**, not leukopenia.
- Classic features include **pharyngitis**, **posterior cervical lymphadenopathy**, **splenomegaly**, and fatigue, which are not present here.
- The lymphocyte percentage (56%) is within normal range for age, not elevated.
*Acute lymphocytic leukemia*
- **ALL** would present with more severe constitutional symptoms (high fever, bone pain, significant fatigue) and typically shows **circulating blasts** on peripheral smear.
- The cytopenias in ALL are usually more profound (severe anemia, marked thrombocytopenia <50,000/mm³).
- The absence of blasts in the differential and relatively preserved hemoglobin (14.2 g/dL) argue against leukemia.
*Acute myelogenous leukemia*
- **AML** presents with severe symptoms including fatigue, bleeding diathesis, and recurrent infections.
- Peripheral smear typically shows **myeloblasts** with Auer rods in some cases.
- The patient's mild symptoms, absence of blasts, and normal hemoglobin make AML highly unlikely.
Question 56: A 54-year-old woman is brought to the emergency department by a nurse 30 minutes after receiving scheduled radiation therapy for papillary thyroid cancer. After the radioisotope was ingested, the physician realized that a much larger fixed dose was given instead of the appropriate dose based on radiation dosimetry. Which of the following pharmacotherapies should be administered immediately to prevent complications from this exposure?
A. Dexrazoxane
B. Methimazole
C. Propylthiouracil
D. Potassium iodide (Correct Answer)
E. Mercaptoethanesulfonate
Explanation: ***Potassium iodide***
- **Potassium iodide (KI)** is the immediate treatment for **radioactive iodine exposure** and works by saturating the thyroid gland with stable, non-radioactive iodine.
- This **competitive inhibition** prevents the uptake of radioactive iodine-131 by the thyroid, thereby reducing the risk of radiation-induced thyroid damage and cancer.
- **Timing is critical**: KI is most effective when given immediately (within hours) after exposure to radioactive iodine.
- The patient received an overdose of **radioactive iodine-131** (commonly used for papillary thyroid cancer treatment), making immediate KI administration the definitive thyroid protective measure.
*Dexrazoxane*
- **Dexrazoxane** is a **cardioprotective agent** used to reduce cardiotoxicity associated with **anthracycline chemotherapy** (e.g., doxorubicin).
- It chelates iron and prevents formation of anthracycline-iron complexes that generate free radicals.
- It has no role in preventing complications from radioactive iodine exposure.
*Methimazole*
- **Methimazole** is an **antithyroid drug** that inhibits thyroid peroxidase, thereby blocking the **iodination and coupling of tyrosyl residues** in thyroid hormone synthesis.
- While it reduces thyroid hormone production, it does **not prevent uptake** of radioactive iodine by the thyroid gland.
- It is ineffective for acute radiation protection in this scenario.
*Propylthiouracil*
- **Propylthiouracil (PTU)** is another **antithyroid drug** that inhibits thyroid peroxidase and also blocks peripheral conversion of **T4 to T3**.
- Like methimazole, PTU does **not prevent radioactive iodine uptake** by the thyroid.
- It is not indicated for acute radioactive iodine exposure management.
*Mercaptoethanesulfonate*
- **Mercaptoethanesulfonate (MESNA)** is a **uroprotective agent** used to prevent hemorrhagic cystitis caused by **oxazaphosphorine chemotherapy agents** (cyclophosphamide and ifosfamide).
- MESNA binds to and detoxifies acrolein, the toxic metabolite responsible for bladder toxicity.
- It has no role in managing radioactive iodine exposure.
Question 57: A 13-year-old Caucasian male presents with his father to the pediatrician’s office complaining of left lower thigh pain. He reports slowly progressive pain over the distal aspect of his left thigh over the past three months. He denies any recent trauma to the area. His temperature is 100.9°F (38.3°C). On exam, there is swelling and tenderness overlying the inferior aspect of the left femoral diaphysis. Laboratory evaluation is notable for an elevated white blood cell (WBC) count and erythrocyte sedimentation rate (ESR). Biopsy of the lesion demonstrates sheets of monotonous small round blue cells with minimal cytoplasm. He is diagnosed and started on a medication that inhibits transcription by intercalating into DNA at the transcription initiation complex. Which of the following adverse events will this patient be at highest risk for following initiation of this medication?
A. Peripheral neuropathy
B. Bone marrow suppression (Correct Answer)
C. Gingival hyperplasia
D. Pulmonary fibrosis
E. Hemorrhagic cystitis
Explanation: ***Bone marrow suppression***
- The medication described, which inhibits transcription by intercalating into DNA at the transcription initiation complex, is likely **dactinomycin (actinomycin D)**.
- **Bone marrow suppression** is a common and severe adverse effect of dactinomycin, leading to issues like **neutropenia** and **thrombocytopenia**.
*Peripheral neuropathy*
- This is a common side effect of **vinca alkaloids** (e.g., vincristine, vinblastine) and **taxanes**, which are not described by the mechanism of action given.
- Dactinomycin does not typically cause significant peripheral neuropathy.
*Gingival hyperplasia*
- **Gingival hyperplasia** is a known side effect of medications such as **cyclosporine**, **phenytoin**, and **calcium channel blockers** like nifedipine.
- It is not associated with dactinomycin.
*Pulmonary fibrosis*
- This is a serious adverse effect of certain chemotherapeutic agents like **bleomycin** and **busulfan**, and other drugs like **amiodarone** and **methotrexate**.
- Dactinomycin is not primarily associated with pulmonary fibrosis.
*Hemorrhagic cystitis*
- **Hemorrhagic cystitis** is a classic adverse effect of **cyclophosphamide** and **ifosfamide**, caused by the metabolite **acrolein**.
- This adverse event is prevented by co-administration of **MESNA**, and is not a common side effect of dactinomycin.
Question 58: A 60-year-old female presents to her primary care physician complaining of bloating and fatigue over the past year. On examination, she has abdominal distension and ascites. Abdominal imaging reveals a mass-like lesion affecting the left ovary. A biopsy of the lesion demonstrates serous cystadenocarcinoma. She is subsequently started on a chemotherapeutic medication known to stabilize polymerized microtubules. Which of the following complications should this patient be monitored for following initiation of this medication?
A. Peripheral neuropathy (Correct Answer)
B. Pulmonary fibrosis
C. Acoustic nerve damage
D. Hemorrhagic cystitis
E. Cardiotoxicity
Explanation: ***Peripheral neuropathy***
- The chemotherapeutic medication described, which stabilizes **polymerized microtubules**, is likely a **taxane** (e.g., paclitaxel, docetaxel), often used for ovarian cancer.
- Taxanes are well-known to cause **dose-dependent peripheral neuropathy** due to their effects on microtubule dynamics in neuronal axons.
*Pulmonary fibrosis*
- **Pulmonary fibrosis** is a significant side effect associated with certain chemotherapeutic agents like **bleomycin** or **busulfan**, but not typically with taxanes.
- Monitoring for this would involve assessing breath sounds, oxygen saturation, and potentially imaging for interstitial changes.
*Acoustic nerve damage*
- **Acoustic nerve damage** and ototoxicity are characteristic side effects of **platinum-based chemotherapy agents** (e.g., cisplatin), which are also used in ovarian cancer but have a different mechanism of action than microtubule stabilizers.
- This typically manifests as **tinnitus** or **hearing loss**.
*Hemorrhagic cystitis*
- **Hemorrhagic cystitis** is a common and severe side effect of **cyclophosphamide** and **ifosfamide**, alkylating agents, due to the accumulation of their metabolite **acrolein** in the bladder.
- It is not associated with microtubule-stabilizing agents like taxanes.
*Cardiotoxicity*
- **Cardiotoxicity**, including dilated cardiomyopathy, is a serious side effect primarily associated with **anthracyclines** (e.g., doxorubicin), which generate free radicals and damage cardiac myocytes.
- While some taxanes can cause cardiovascular effects, severe cardiotoxicity like that seen with anthracyclines is not their primary or most concerning side effect.
Question 59: A 26-year-old man comes to the emergency department because of a 1-week history of worsening fatigue, nausea, and vomiting. Six weeks ago, he was diagnosed with latent tuberculosis and appropriate low-dose pharmacotherapy was initiated. Physical examination shows right upper quadrant tenderness and scleral icterus. Laboratory studies show elevated aminotransferases. Impaired function of which of the following pharmacokinetic processes is the most likely explanation for this patient's symptoms?
A. Acetylation (Correct Answer)
B. Glucuronidation
C. Hydrolysis
D. Sulfation
E. Reduction
Explanation: ***Acetylation***
- This patient is exhibiting symptoms of **hepatotoxicity** (fatigue, nausea, vomiting, RUQ tenderness, scleral icterus, elevated aminotransferases) after starting low-dose pharmacotherapy for latent tuberculosis. The most common drug used for latent TB is **isoniazid**, which is primarily metabolized by **N-acetylation**.
- Impaired acetylation, particularly in **slow acetylators**, can lead to higher plasma concentrations of isoniazid and its toxic metabolites, increasing the risk of **drug-induced liver injury**.
*Glucuronidation*
- **Glucuronidation** is a Phase II metabolic pathway that conjugates drugs with **glucuronic acid** to increase water solubility and facilitate excretion.
- While important for the metabolism of many drugs and endogenous substances (e.g., bilirubin), it is not the primary mechanism of metabolism or the main pathway implicated in the hepatotoxicity of **isoniazid**.
*Hydrolysis*
- **Hydrolysis** is a chemical reaction in which water is used to break down a compound, often involving ester or amide bonds.
- This process is not the primary metabolic pathway for **isoniazid**, nor is impaired hydrolysis a common cause of its hepatotoxicity.
*Sulfation*
- **Sulfation** is a Phase II metabolic reaction that conjugates drugs with a **sulfate group**, typically for detoxification and excretion.
- While various drugs undergo sulfation, it is not the dominant metabolic pathway for **isoniazid**, and impaired sulfation is not typically associated with isoniazid-induced hepatotoxicity.
*Reduction*
- **Reduction** reactions involve the gain of electrons or hydrogen atoms, or the loss of oxygen, and are part of drug metabolism for certain compounds.
- However, reduction is not the primary clearance mechanism for **isoniazid**, and abnormal reduction is not commonly implicated in its hepatotoxic effects.
Question 60: A 67-year-old male with a past medical history of diabetes type II, obesity, and hyperlipidemia presents to the general medical clinic with bilateral hearing loss. He also reports new onset vertigo and ataxia. The symptoms started a day after undergoing an uncomplicated cholecystectomy. If a drug given prophylactically just prior to surgery has caused this patient’s symptoms, what is the mechanism of action of the drug?
A. Formation of free radical toxic metabolites that damage DNA
B. Inhibition of the formation of the translation initiation complex (Correct Answer)
C. Inhibition of DNA gyrase
D. Inhibition of cell wall synthesis
E. Inhibition of DNA-dependent RNA polymerase
Explanation: **Correct: Inhibition of the formation of the translation initiation complex**
- The symptoms of **bilateral hearing loss**, **vertigo**, and **ataxia** point to **ototoxicity** and **vestibulotoxicity**, which are classic side effects of **aminoglycoside antibiotics**.
- Aminoglycosides, such as gentamicin, are known to **inhibit bacterial protein synthesis** by binding to the **30S ribosomal subunit**, thereby **inhibiting the formation of the translation initiation complex**. They are sometimes used prophylactically, though less commonly for cholecystectomy.
*Incorrect: Formation of free radical toxic metabolites that damage DNA*
- This mechanism is characteristic of **nitrofurans** (e.g., nitrofurantoin) and some **antimalarials**, which are not typically used for surgical prophylaxis.
- While these drugs can cause various adverse effects, this specific mechanism does not lead to the described triad of ototoxicity and vestibulotoxicity.
*Incorrect: Inhibition of DNA gyrase*
- This is the mechanism of action for **fluoroquinolone antibiotics** (e.g., ciprofloxacin, levofloxacin).
- While fluoroquinolones can cause adverse effects like tendinopathy and CNS disturbances, they are not typically associated with the pronounced ototoxicity and vestibulotoxicity seen in this patient.
*Incorrect: Inhibition of cell wall synthesis*
- This is the mechanism of action for **beta-lactam antibiotics** (e.g., penicillin, cephalosporins) and **vancomycin**, which are common choices for surgical prophylaxis.
- Though some of these drugs can have side effects (e.g., vancomycin's "red man syndrome" or ototoxicity in specific cases), the combination of bilateral hearing loss, vertigo, and ataxia is not their characteristic adverse effect profile.
*Incorrect: Inhibition of DNA-dependent RNA polymerase*
- This is the mechanism of action for **rifamycins** (e.g., rifampin).
- Rifampin is primarily used for tuberculosis and some other serious infections, not typically for routine surgical prophylaxis, and its side effect profile does not include this specific constellation of ototoxicity and vestibulotoxicity.